| Primary |
| Product Used For Unknown Indication |
99.2% |
| Depression |
0.4% |
| Anxiety Disorder |
0.2% |
| Panic Attack |
0.2% |
|
| Toxicity To Various Agents |
83.6% |
| Respiratory Arrest |
5.0% |
| Intentional Drug Misuse |
3.7% |
| Drug Abuse |
3.2% |
| Completed Suicide |
1.4% |
| Unresponsive To Stimuli |
0.9% |
| Death |
0.5% |
| Deep Vein Thrombosis |
0.5% |
| Product Substitution Issue |
0.5% |
| Thirst |
0.5% |
| Urinary Tract Infection |
0.5% |
|
| Secondary |
| Product Used For Unknown Indication |
71.5% |
| Completed Suicide |
9.8% |
| Depression |
2.8% |
| Intentional Self-injury |
2.3% |
| Analgesic Therapy |
1.9% |
| Anxiety Disorder |
1.9% |
| Bipolar Ii Disorder |
1.9% |
| Psychotic Disorder |
1.9% |
| Anxiety |
0.9% |
| Pain |
0.9% |
| Parkinson's Disease |
0.9% |
| Cutaneous Lupus Erythematosus |
0.5% |
| Drug Abuse |
0.5% |
| Fibromyalgia |
0.5% |
| Muscle Contracture |
0.5% |
| Myocardial Infarction |
0.5% |
| Panic Disorder |
0.5% |
| Tuberous Sclerosis |
0.5% |
|
| Toxicity To Various Agents |
37.0% |
| Respiratory Arrest |
14.8% |
| Drug Abuse |
13.6% |
| Completed Suicide |
4.9% |
| Sopor |
3.7% |
| Speech Disorder |
3.7% |
| Intentional Drug Misuse |
2.5% |
| Suicide Attempt |
2.5% |
| Tremor |
2.5% |
| Unevaluable Event |
2.5% |
| Death |
1.2% |
| Exposure Via Ingestion |
1.2% |
| Haematoma |
1.2% |
| Maternal Drugs Affecting Foetus |
1.2% |
| Micturition Urgency |
1.2% |
| Panic Disorder |
1.2% |
| Poisoning |
1.2% |
| Post Procedural Complication |
1.2% |
| Pregnancy |
1.2% |
| Serotonin Syndrome |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.3% |
| Multiple Sclerosis |
14.6% |
| Plasma Cell Myeloma |
14.0% |
| Drug Use For Unknown Indication |
13.4% |
| Osteoporosis Prophylaxis |
6.1% |
| Chronic Myeloid Leukaemia |
3.7% |
| Prostate Cancer Metastatic |
3.7% |
| Hypertension |
3.0% |
| Immunodeficiency Common Variable |
3.0% |
| Osteoporosis |
3.0% |
| Fibromyalgia |
2.4% |
| Gait Disturbance |
2.4% |
| Coronary Artery Disease |
1.8% |
| Depression |
1.8% |
| Ill-defined Disorder |
1.8% |
| Nephrogenic Anaemia |
1.8% |
| Abnormal Behaviour |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Gout |
1.2% |
|
| White Blood Cell Count Decreased |
11.9% |
| Vomiting |
9.0% |
| Urinary Tract Infection |
7.5% |
| Pain |
6.0% |
| Pneumonia |
6.0% |
| Tremor |
6.0% |
| Visual Impairment |
6.0% |
| Pain In Extremity |
4.5% |
| Pyrexia |
4.5% |
| Rash |
4.5% |
| Staphylococcal Infection |
4.5% |
| Thrombocytopenia |
4.5% |
| Vision Blurred |
4.5% |
| Constipation |
3.0% |
| Drug Ineffective |
3.0% |
| Loss Of Consciousness |
3.0% |
| Neutropenia |
3.0% |
| Off Label Use |
3.0% |
| Paraesthesia |
3.0% |
| Platelet Count Decreased |
3.0% |
|
